EMERYVILLE, Calif., Sept. 21, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon® platform at the 16th annual Conference on Protein Expression in Animal Cells, which is being held…Read More
PhenomeX Announces the Release of SpotLight Human Lambda Reagent for the Beacon Platform to Accelerate Cell Line Development Workflows
